发明名称 SAQUINAVIR MESYLATE ORAL DOSAGE FORM
摘要 PROBLEM TO BE SOLVED: To provide a solid unit oral pharmaceutical dosage form of saquinavir mesylate having a uniform and rapid dissolution profile. SOLUTION: The oral solid dosage form is provided comprising micronized saquinavir mesylate in an amount of from 250 to 800 mg calculated as free base, and a pharmaceutically acceptable binder, disintegrant and a water-soluble carrier. The solid unit dosage form of saquinavir mesylate comprises 60-80% micronized saquinavir mesylate based on the mesylate salt, 4-8% water-soluble binder, a disintegrant, and a carrier, wherein each percentage is of the kernel weight. COPYRIGHT: (C)2011,JPO&INPIT
申请公布号 JP2010280707(A) 申请公布日期 2010.12.16
申请号 JP20100181350 申请日期 2010.08.13
申请人 F HOFFMANN LA ROCHE AG 发明人 ALBANO ANTONIO A;INFELD MARTIN HOWARD;PHUAPRADIT WANTANEE;SHAH NAVNIT-HARGOVINDAS;ZHANG LIN
分类号 A61K31/4725;A61K9/00;A61K9/20;A61K9/28;A61K9/48;A61K9/56;A61K31/551;A61K47/12;A61K47/26;A61K47/32;A61K47/38;A61P31/18;A61P43/00 主分类号 A61K31/4725
代理机构 代理人
主权项
地址